Please enable JavaScript to continue using this application.

Compare $COAG vs $XNCR | Chartloom

Compare

$COAG vs $XNCR

Hemab Therapeutics Holdings Inc · Xencor Inc

COAG

Hemab Therapeutics Holdings Inc

XNCR

Xencor Inc

Compare $COAG vs $XNCR

Comparing Hemab Therapeutics Holdings Inc and Xencor Inc

COAGHemab Therapeutics Holdings Inc

XNCRXencor Inc

COAGHemab Therapeutics Holdings Inc

Market cap

$1.48B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-7.0%

52W performance

-7.0%

FCF yield

0.0%

XNCRXencor Inc

Market cap

$1.83B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

14.26x

Rev growth (TTM)

-33.2%

YTD performance

65.1%

52W performance

98.6%

FCF yield

-11.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

COAG

XNCR

Detailed metrics comparison

COAG

Hemab Therapeutics Holdings Inc

XNCR

Xencor Inc

Market Cap

COAG$1.48B

XNCR$1.83B

Enterprise Value

COAG$1.24B

XNCR$1.89B

Price

COAG$31.62

XNCR$24.63

P/E Ratio

COAGN/A

XNCRN/A

P/S Ratio

COAG0.00x

XNCR17.40x

EV/Sales

COAG0.00x

XNCR17.97x

EV/EBITDA

COAG0.00x

XNCR31.73x

P/B Ratio

COAG3.20x

XNCR3.71x

P/FCF Ratio

COAGN/A

XNCRN/A

EV/FCF

COAG0.00x

XNCR-9.06x

PEG Ratio

COAGN/A

XNCRN/A

Forward P/E (NTM)

COAGN/A

XNCRN/A

Forward P/S (NTM)

COAGN/A

XNCR14.26x

Revenue (TTM)

COAG$0

XNCR$105M

Revenue Growth (YoY)

COAGN/A

XNCR-33.2%

Forward Rev Growth

COAG1014.0%

XNCR7.4%

Gross Margin (TTM)

COAG0.0%

XNCR0.0%

Operating Margin (TTM)

COAG0.0%

XNCR0.0%

EBITDA Margin (TTM)

COAG0.0%

XNCR-188.5%

Net Margin (TTM)

COAG0.0%

XNCR-155.6%

FCF Margin (TTM)

COAGN/A

XNCR-198.4%

Net Income (TTM)

COAG$-47M

XNCR$-163M

FCF (TTM)

COAG$0

XNCR$-208M

EPS (TTM)

COAG-$1.00

XNCR-$2.15

ROE (TTM)

COAG0.0%

XNCR-2866.0%

ROA (TTM)

COAG0.0%

XNCR-2038.0%

ROIC (TTM)

COAG0.0%

XNCR-2379.0%

Cash

COAG$237M

XNCR$45M

Debt

COAG$0

XNCR$105M

Net Cash/Debt

COAG$237M

XNCR$-60M

Current Ratio (TTM)

COAG35.85x

XNCR6.39x

Quick Ratio (TTM)

COAG35.48x

XNCR6.09x

Debt/Equity (TTM)

COAG0.00x

XNCR0.21x

Debt/Assets (TTM)

COAG0.0%

XNCR0.0%

Interest Coverage (TTM)

COAGN/A

XNCRN/A

Net Debt/EBITDA (TTM)

COAG0.00x

XNCR0.00x

Beta

COAG-0.87

XNCR0.81

52W Performance

COAG-7.0%

XNCR98.6%

YTD Performance

COAG-7.0%

XNCR65.1%

% from 52W High

COAG-42.9%

XNCR-19.5%

% from 52W Low

COAG37.5%

XNCR137.4%

Asset Turnover (TTM)

COAG0.00x

XNCR0.13x

FCF Yield (TTM)

COAG0.0%

XNCR-11.4%

Earnings Yield (TTM)

COAG-3.2%

XNCR-8.9%

Dividend Yield (TTM)

COAGN/A

XNCRN/A

Rule of 40

COAG0.0

XNCR-231.6

EV/GP/RG

COAGN/A

XNCRN/A

Ticker research

View COAG research View XNCR research

Metric	COAG Hemab Therapeutics Holdings Inc	XNCR Xencor Inc
Market & Valuation
Market Cap	$1.48B	$1.83B
Enterprise Value	$1.24B	$1.89B
Price	$31.62	$24.63
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	17.40x
EV/Sales	0.00x	17.97x
EV/EBITDA	0.00x	31.73x
P/B Ratio	3.20x	3.71x
P/FCF Ratio	N/A	N/A
EV/FCF	0.00x	-9.06x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	14.26x
Revenue & Growth
Revenue (TTM)	$0	$105M
Revenue Growth (YoY)	N/A	-33.2%
Forward Rev Growth	1014.0%	7.4%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-188.5%
Net Margin (TTM)	0.0%	-155.6%
FCF Margin (TTM)	N/A	-198.4%
Net Income (TTM)	$-47M	$-163M
FCF (TTM)	$0	$-208M
EPS (TTM)	-$1.00	-$2.15
ROE (TTM)	0.0%	-2866.0%
ROA (TTM)	0.0%	-2038.0%
ROIC (TTM)	0.0%	-2379.0%
Financial Health
Cash	$237M	$45M
Debt	$0	$105M
Net Cash/Debt	$237M	$-60M
Current Ratio (TTM)	35.85x	6.39x
Quick Ratio (TTM)	35.48x	6.09x
Debt/Equity (TTM)	0.00x	0.21x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.87	0.81
52W Performance	-7.0%	98.6%
YTD Performance	-7.0%	65.1%
% from 52W High	-42.9%	-19.5%
% from 52W Low	37.5%	137.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.13x
FCF Yield (TTM)	0.0%	-11.4%
Earnings Yield (TTM)	-3.2%	-8.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-231.6
EV/GP/RG	N/A	N/A
Ticker research	View COAG research	View XNCR research

Valuation

P/S Ratio

COAG

0.00x

XNCR

17.40x

EV/FCF

XNCR

-9.06x

COAG

0.00x

Growth & revenue

Revenue Growth TTM

XNCR

-33.2%

Forward Revenue Growth

COAG

1014.0%

XNCR

7.4%

Profitability & performance

Gross Margin

COAG

0.0%

XNCR

0.0%

ROE

COAG

0.0%

XNCR

-2866.0%

FCF Yield %

COAG

0.0%

XNCR

-11.4%

52-Week Performance

XNCR

98.6%

COAG

-7.0%

Detailed metrics comparison

COAG

Hemab Therapeutics Holdings Inc

XNCR

Xencor Inc

Market Cap

COAG$1.48B

XNCR$1.83B

Enterprise Value

COAG$1.24B

XNCR$1.89B

Price

COAG$31.62

XNCR$24.63

P/E Ratio

COAGN/A

XNCRN/A

P/S Ratio

COAG0.00x

XNCR17.40x

EV/Sales

COAG0.00x

XNCR17.97x

EV/EBITDA

COAG0.00x

XNCR31.73x

P/B Ratio

COAG3.20x

XNCR3.71x

P/FCF Ratio

COAGN/A

XNCRN/A

EV/FCF

COAG0.00x

XNCR-9.06x

PEG Ratio

COAGN/A

XNCRN/A

Forward P/E (NTM)

COAGN/A

XNCRN/A

Forward P/S (NTM)

COAGN/A

XNCR14.26x

Revenue (TTM)

COAG$0

XNCR$105M

Revenue Growth (YoY)

COAGN/A

XNCR-33.2%

Forward Rev Growth

COAG1014.0%

XNCR7.4%

Gross Margin (TTM)

COAG0.0%

XNCR0.0%

Operating Margin (TTM)

COAG0.0%

XNCR0.0%

EBITDA Margin (TTM)

COAG0.0%

XNCR-188.5%

Net Margin (TTM)

COAG0.0%

XNCR-155.6%

FCF Margin (TTM)

COAGN/A

XNCR-198.4%

Net Income (TTM)

COAG$-47M

XNCR$-163M

FCF (TTM)

COAG$0

XNCR$-208M

EPS (TTM)

COAG-$1.00

XNCR-$2.15

ROE (TTM)

COAG0.0%

XNCR-2866.0%

ROA (TTM)

COAG0.0%

XNCR-2038.0%

ROIC (TTM)

COAG0.0%

XNCR-2379.0%

Cash

COAG$237M

XNCR$45M

Debt

COAG$0

XNCR$105M

Net Cash/Debt

COAG$237M

XNCR$-60M

Current Ratio (TTM)

COAG35.85x

XNCR6.39x

Quick Ratio (TTM)

COAG35.48x

XNCR6.09x

Debt/Equity (TTM)

COAG0.00x

XNCR0.21x

Debt/Assets (TTM)

COAG0.0%

XNCR0.0%

Interest Coverage (TTM)

COAGN/A

XNCRN/A

Net Debt/EBITDA (TTM)

COAG0.00x

XNCR0.00x

Beta

COAG-0.87

XNCR0.81

52W Performance

COAG-7.0%

XNCR98.6%

YTD Performance

COAG-7.0%

XNCR65.1%

% from 52W High

COAG-42.9%

XNCR-19.5%

% from 52W Low

COAG37.5%

XNCR137.4%

Asset Turnover (TTM)

COAG0.00x

XNCR0.13x

FCF Yield (TTM)

COAG0.0%

XNCR-11.4%

Earnings Yield (TTM)

COAG-3.2%

XNCR-8.9%

Dividend Yield (TTM)

COAGN/A

XNCRN/A

Rule of 40

COAG0.0

XNCR-231.6

EV/GP/RG

COAGN/A

XNCRN/A

Ticker research

View COAG research View XNCR research

Metric	COAG Hemab Therapeutics Holdings Inc	XNCR Xencor Inc
Market & Valuation
Market Cap	$1.48B	$1.83B
Enterprise Value	$1.24B	$1.89B
Price	$31.62	$24.63
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	17.40x
EV/Sales	0.00x	17.97x
EV/EBITDA	0.00x	31.73x
P/B Ratio	3.20x	3.71x
P/FCF Ratio	N/A	N/A
EV/FCF	0.00x	-9.06x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	14.26x
Revenue & Growth
Revenue (TTM)	$0	$105M
Revenue Growth (YoY)	N/A	-33.2%
Forward Rev Growth	1014.0%	7.4%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-188.5%
Net Margin (TTM)	0.0%	-155.6%
FCF Margin (TTM)	N/A	-198.4%
Net Income (TTM)	$-47M	$-163M
FCF (TTM)	$0	$-208M
EPS (TTM)	-$1.00	-$2.15
ROE (TTM)	0.0%	-2866.0%
ROA (TTM)	0.0%	-2038.0%
ROIC (TTM)	0.0%	-2379.0%
Financial Health
Cash	$237M	$45M
Debt	$0	$105M
Net Cash/Debt	$237M	$-60M
Current Ratio (TTM)	35.85x	6.39x
Quick Ratio (TTM)	35.48x	6.09x
Debt/Equity (TTM)	0.00x	0.21x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.87	0.81
52W Performance	-7.0%	98.6%
YTD Performance	-7.0%	65.1%
% from 52W High	-42.9%	-19.5%
% from 52W Low	37.5%	137.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.13x
FCF Yield (TTM)	0.0%	-11.4%
Earnings Yield (TTM)	-3.2%	-8.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-231.6
EV/GP/RG	N/A	N/A
Ticker research	View COAG research	View XNCR research